SecBot SecBot
SECBOTREPLAY Home › Report › ORKA

ORKA · Oruka Therapeutics' $1 billion shelf registration (S-3) has become…

Oruka Therapeutics, Inc. · EFFECT filed Apr 13, 2026 at 00:15 ET

At the news

NEUTRALIMPACT 3/10

EFFECT filed Apr 13, 2026 at 00:15 ET

Oruka Therapeutics' $1 billion shelf registration (S-3) has become effective, allowing the company to sell common stock, preferred stock, depositary shares, or warrants from time to time. This creates a potential for future dilution, though no immediate offering has been announced.

  • S-3 shelf registration effective as of April 10, 2026
  • Registration allows for up to $1 billion in securities to be offered
  • Securities may include common stock, preferred stock, depositary shares, or warrants
  • Offerings can occur at any time over the next three years, with terms disclosed in future prospectus supplements

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access